Management of Human Immunodeficiency Virus Infection in Advanced Age

Overview

Journal JAMA

Publisher American Medical Association

Specialty General Medicine

Date 2013 Apr 4

PMID 23549585

Citations 95

Authors

Meredith Greene

Amy C Justice

Harry W Lampiris

Victor Valcour

Affiliations

Soon will be listed here.

Abstract

Importance: Human immunodeficiency virus (HIV)-positive patients treated with antiretroviral therapy now have increased life expectancy and develop chronic illnesses that are often seen in older HIV-negative patients.

Objective: To address emerging issues related to aging with HIV. Screening older adults for HIV, diagnosis of concomitant diseases, management of multiple comorbid medical illnesses, social isolation, polypharmacy, and factors associated with end-of-life care are reviewed.

Evidence Acquisition: Published guidelines and consensus statements were reviewed. PubMed and PsycINFO were searched between January 2000 and February 2013. Articles not appearing in the search that were referenced by reviewed articles were also evaluated.

Findings: The population of older HIV-positive patients is rapidly expanding. It is estimated that by 2015 one-half of the individuals in the United States with HIV will be older than age 50. Older HIV-infected patients are prone to having similar chronic diseases as their HIV-negative counterparts, as well as illnesses associated with co-infections. Medical treatments associated with these conditions, when added to an antiretroviral regimen, increase risk for polypharmacy. Care of aging HIV-infected patients involves a need to balance a number of concurrent comorbid medical conditions.

Conclusions And Relevance: HIV is no longer a fatal disease. Management of multiple comorbid diseases is a common feature associated with longer life expectancy in HIV-positive patients. There is a need to better understand how to optimize the care of these patients.

Citing Articles

Demographic and clinical characteristics of New York City Health + Hospitals HIV Heart Failure (NYC4H cohort): cohort profile.

Chen Y, Borkowski P, Nazarenko N, Biavati L, Parker M, Chowdhury I BMJ Open. 2024; 14(10):e085081.

PMID: 39477254 PMC: 11529568. DOI: 10.1136/bmjopen-2024-085081.

United Voices Group-Singing Intervention to Address Loneliness and Social Isolation Among Older People With HIV During the COVID-19 Pandemic: Intervention Adaption Study.

Hill M, Greene M, Johnson J, Tan J JMIR Form Res. 2024; 8:e60387.

PMID: 39378071 PMC: 11496909. DOI: 10.2196/60387.

Enhancing the delivery of comprehensive care for people living with HIV in Canada: insights from citizen panels and a national stakeholder dialogue.

Wilson M, Mattison C, Waddell K, Bacon J, Becker M, Bibeau C Health Res Policy Syst. 2024; 22(1):62.

PMID: 38802942 PMC: 11129410. DOI: 10.1186/s12961-024-01147-1.

Sex differences in health-related quality of life and poverty risk among older people living with HIV in Spain: A cross-sectional study.

Nuno N, Martinez A, Martinez S, Cobos M, Hernandez J, Polo R PLoS One. 2024; 19(5):e0301335.

PMID: 38713682 PMC: 11075874. DOI: 10.1371/journal.pone.0301335.

Prevalence and Correlates of Physical Inactivity Among Individuals with HIV During the First COVID-19 Wave: A Cross-sectional Survey.

Harsono D, Deng Y, Chung S, Barakat L, Friedland G, Villanueva M AIDS Behav. 2023; 28(5):1531-1545.

PMID: 37824037 PMC: 11349050. DOI: 10.1007/s10461-023-04170-5.

References

Walter L, Covinsky K . Cancer screening in elderly patients: a framework for individualized decision making. JAMA. 2001; 285(21):2750-6. DOI: 10.1001/jama.285.21.2750. View

Womack J, Goulet J, Gibert C, Brandt C, Skanderson M, Gulanski B . Physiologic frailty and fragility fracture in HIV-infected male veterans. Clin Infect Dis. 2013; 56(10):1498-504. PMC: 3634308. DOI: 10.1093/cid/cit056. View

Hasse B, Ledergerber B, Furrer H, Battegay M, Hirschel B, Cavassini M . Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study. Clin Infect Dis. 2011; 53(11):1130-9. DOI: 10.1093/cid/cir626. View

Rosenthal E, Pialoux G, Bernard N, Pradier C, Rey D, Bentata M . Liver-related mortality in human-immunodeficiency-virus-infected patients between 1995 and 2003 in the French GERMIVIC Joint Study Group Network (MORTAVIC 2003 Study). J Viral Hepat. 2007; 14(3):183-8. DOI: 10.1111/j.1365-2893.2006.00791.x. View

Prejean J, Song R, Hernandez A, Ziebell R, Green T, Walker F . Estimated HIV incidence in the United States, 2006-2009. PLoS One. 2011; 6(8):e17502. PMC: 3149556. DOI: 10.1371/journal.pone.0017502. View

Jacobs R, Kane M . Theory-based policy development for HIV prevention in racial/ethnic minority midlife and older women. J Women Aging. 2009; 21(1):19-32. DOI: 10.1080/08952840802633586. View

Crystal S, Akincigil A, Sambamoorthi U, Wenger N, Fleishman J, Zingmond D . The diverse older HIV-positive population: a national profile of economic circumstances, social support, and quality of life. J Acquir Immune Defic Syndr. 2003; 33 Suppl 2:S76-83. View

OBrien K, Nixon S, Tynan A, Glazier R . Aerobic exercise interventions for adults living with HIV/AIDS. Cochrane Database Syst Rev. 2010; (8):CD001796. PMC: 7061352. DOI: 10.1002/14651858.CD001796.pub3. View

Balderson B, Grothaus L, Harrison R, McCoy K, Mahoney C, Catz S . Chronic illness burden and quality of life in an aging HIV population. AIDS Care. 2012; 25(4):451-8. PMC: 3535557. DOI: 10.1080/09540121.2012.712669. View

10.

Erlandson K, Allshouse A, Duong S, MaWhinney S, Kohrt W, Campbell T . HIV, aging, and advance care planning: are we successfully planning for the future?. J Palliat Med. 2012; 15(10):1124-9. PMC: 3438835. DOI: 10.1089/jpm.2011.0510. View

11.

Sanders G, Bayoumi A, Holodniy M, Owens D . Cost-effectiveness of HIV screening in patients older than 55 years of age. Ann Intern Med. 2008; 148(12):889-903. PMC: 3428219. DOI: 10.7326/0003-4819-148-12-200806170-00002. View

12.

Monforte A, Abrams D, Pradier C, Weber R, Reiss P, Bonnet F . HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies. AIDS. 2008; 22(16):2143-53. PMC: 2715844. DOI: 10.1097/QAD.0b013e3283112b77. View

13.

Yehia B, Fleishman J, Metlay J, Moore R, Gebo K . Sustained viral suppression in HIV-infected patients receiving antiretroviral therapy. JAMA. 2012; 308(4):339-42. PMC: 3541503. DOI: 10.1001/jama.2012.5927. View

14.

Rabkin M, Kruk M, El-Sadr W . HIV, aging and continuity care: strengthening health systems to support services for noncommunicable diseases in low-income countries. AIDS. 2012; 26 Suppl 1:S77-83. DOI: 10.1097/QAD.0b013e3283558430. View

15.

. Screening for HIV: recommendation statement. Ann Intern Med. 2005; 143(1):32-7. DOI: 10.7326/0003-4819-143-1-200507050-00008. View

16.

Shiels M, Cole S, Kirk G, Poole C . A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals. J Acquir Immune Defic Syndr. 2009; 52(5):611-22. PMC: 2790038. DOI: 10.1097/QAI.0b013e3181b327ca. View

17.

Steinman M, Hanlon J . Managing medications in clinically complex elders: "There's got to be a happy medium". JAMA. 2010; 304(14):1592-601. PMC: 2981606. DOI: 10.1001/jama.2010.1482. View

18.

Aberg J, Kaplan J, Libman H, Emmanuel P, Anderson J, Stone V . Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2009; 49(5):651-81. DOI: 10.1086/605292. View

19.

Furler M, Einarson T, Walmsley S, Millson M, Bendayan R . Polypharmacy in HIV: impact of data source and gender on reported drug utilization. AIDS Patient Care STDS. 2005; 18(10):568-86. DOI: 10.1089/apc.2004.18.568. View

20.

Desquilbet L, Jacobson L, Fried L, Phair J, Jamieson B, Holloway M . HIV-1 infection is associated with an earlier occurrence of a phenotype related to frailty. J Gerontol A Biol Sci Med Sci. 2007; 62(11):1279-86. DOI: 10.1093/gerona/62.11.1279. View